Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03755518
Title An Efficacy and Safety Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib (FREEDOM)
Acronym FREEDOM
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Local Institution - 117 Aurora Colorado 80045 United States Details
Local Institution - 126 Miami Florida 33176 United States Details
Local Institution - 113 Augusta Georgia 30912 United States Details
Local Institution - 112 Chicago Illinois 60612 United States Details
Local Institution - 109 Chicago Illinois 60637 United States Details
Local Institution - 121 Park Ridge Illinois 60068 United States Details
Local Institution - 100 Kansas City Kansas 66160-7314 United States Details
Local Institution - 123 Baltimore Maryland 21229-5299 United States Details
Local Institution - 118 Bethesda Maryland 20817 United States Details
Local Institution - 127 Columbia Maryland 21044 United States Details
Local Institution - 103 Ann Arbor Michigan 48109 United States Details
Local Institution - 101 Saint Louis Missouri 63110 United States Details
Local Institution - 128 Newark New Jersey 07112-2027 United States Details
Local Institution - 130 Brooklyn New York 11212 United States Details
Local Institution - 115 New York New York 10029 United States Details
Local Institution - 124 New York New York 10032 United States Details
SUNY Upstate Medical University Syracuse New York 13210 United States Details
Local Institution - 105 Chapel Hill North Carolina 27514 United States Details
Local Institution - 114 Durham North Carolina 27705 United States Details
Local Institution - 111 Cincinnati Ohio 45219 United States Details
Local Institution - 106 Pittsburgh Pennsylvania 15224 United States Details
Local Institution - 108 Sioux Falls South Dakota 57105 United States Details
Local Institution - 119 Dallas Texas 75390-8852 United States Details
Local Institution - 132 Fort Worth Texas 76104 United States Details
Local Institution - 110 Houston Texas 77303 United States Details
Local Institution - 120 San Antonio Texas 78229 United States Details
Local Institution - 116 Seattle Washington 98109 United States Details
Local Institution - 129 Madison Wisconsin 53792-2454 United States Details
Local Institution - 203 Vancouver British Columbia V6Z 2A5 Canada Details
Local Institution - 207 London Ontario N6C 6B5 Canada Details
Local Institution - 205 Ottawa Ontario K1H 8L6 Canada Details
Local Institution - 200 Toronto Ontario M5G 2M9 Canada Details
Local Institution - 201 Montreal Quebec H1T 2M4 Canada Details
Local Institution - 202 Montreal Quebec H3T 1E2 Canada Details
Local Institution - 204 Sherbrooke Quebec J1K 2R1 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field